47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
77.11.Z - Rental and leasing of passenger cars and light motor vehicles
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,7 | 2,2 | 1,1 | -50,9 |
EBITDA | 3,8 | 1,7 | 0,8 | -51,9 |
Short time liabilities | 10,8 | 11,3 | 11,6 | 3,2 |
Equity capital | 4,3 | 2,2 | 1,9 | -10,5 |
Operating profit (EBIT) | 3,6 | 1,4 | 0,6 | -57,4 |
Assets | 15,7 | 13,7 | 13,8 | 0,9 |
Net profit (loss) | 3,2 | 1,9 | 1 | -49,6 |
Cash | 1,2 | 2,2 | 2,3 | 7,2 |
Net income from sale | 52,7 | 56,9 | 59,2 | 4 |
Liabilities and provisions for liabilities | 11,4 | 11,5 | 11,9 | 3 |
Working assets | 14 | 12,1 | 11,1 | -8,5 |
Depreciation | 0,2 | 0,3 | 0,2 | -24,1 |
% | % | % | p.p. | |
Profitability of capital | 74,1 | 88,3 | 49,7 | -38,6 |
Equity capital to total assets | 27,3 | 15,8 | 14 | -1,8 |
Gross profit margin | 7,1 | 4 | 1,9 | -2,1 |
EBITDA Margin | 7,2 | 3 | 1,4 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 75 | 72 | 72 | 0 |
Current financial liquidity indicator | 1.2953884601593018 | 1.0715415477752686 | 0.9495195150375366 | -0,2 |
Net dept to EBITDA | -0.08799145370721817 | -1.079641580581665 | -2.8714425563812256 | -1,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane